Management of benign intracranial hypertension (pseudotumor cerebri).
D000747:Anemia, Hypochromic / Q000150:complications; D001416:Back Pain / Q000209:etiology; D001927:Brain Diseases / Q000628:therapy*; D014695:Cerebral Ventriculography; D002561:Cerebrovascular Disorders / Q000150:complications; D002648:Child; D006259:Craniocerebral Trauma / Q000150:complications; D003399:Craniotomy; D004700:Endocrine System Diseases / Q000150:complications; D005260:Female; D005831:Genital Diseases, Female / Q000150:complications; D006801:Humans; D007427:Intracranial Pressure; D009268:Nalidixic Acid / Q000009:adverse effects; D011183:Postoperative Complications; D011559:Pseudotumor Cerebri / Q000139:chemically induced / Q000150:complications / Q000000981:diagnostic imaging / Q000209:etiology / Q000601:surgery / Q000628:therapy; D012640:Seizures / Q000209:etiology; D013129:Spinal Puncture; D013752:Tetracycline / Q000009:adverse effects; D014801:Vitamin A / Q000009:adverse effects; D014923:Wiskott-Aldrich Syndrome / Q000150:complications
D014801:Vitamin A; D009268:Nalidixic Acid; D013752:Tetracycline